ATE82567T1 - 0-alkanoyl-derivate der 3-amino-2hydroxypropanesulfons|ure mit antikonvulsiver wirkung und diese enthaltende pharmazeutische mittel zur therapeutischen behandlung der epilepsie. - Google Patents

0-alkanoyl-derivate der 3-amino-2hydroxypropanesulfons|ure mit antikonvulsiver wirkung und diese enthaltende pharmazeutische mittel zur therapeutischen behandlung der epilepsie.

Info

Publication number
ATE82567T1
ATE82567T1 AT88830373T AT88830373T ATE82567T1 AT E82567 T1 ATE82567 T1 AT E82567T1 AT 88830373 T AT88830373 T AT 88830373T AT 88830373 T AT88830373 T AT 88830373T AT E82567 T1 ATE82567 T1 AT E82567T1
Authority
AT
Austria
Prior art keywords
amino
epilepsy
acids
therapeutic treatment
pharmaceutical agents
Prior art date
Application number
AT88830373T
Other languages
English (en)
Inventor
Carlo Alberto Bagolini
Licia Pacifici
Emma Teresa Quaresima
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE82567T1 publication Critical patent/ATE82567T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88830373T 1987-09-21 1988-09-19 0-alkanoyl-derivate der 3-amino-2hydroxypropanesulfons|ure mit antikonvulsiver wirkung und diese enthaltende pharmazeutische mittel zur therapeutischen behandlung der epilepsie. ATE82567T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8748404A IT1211792B (it) 1987-09-21 1987-09-21 O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
EP88830373A EP0309421B1 (de) 1987-09-21 1988-09-19 0-Alkanoyl-Derivate der 3-Amino-2-hydroxypropanesulfonsäure mit antikonvulsiver Wirkung und diese enthaltende pharmazeutische Mittel zur therapeutischen Behandlung der Epilepsie

Publications (1)

Publication Number Publication Date
ATE82567T1 true ATE82567T1 (de) 1992-12-15

Family

ID=11266349

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88830373T ATE82567T1 (de) 1987-09-21 1988-09-19 0-alkanoyl-derivate der 3-amino-2hydroxypropanesulfons|ure mit antikonvulsiver wirkung und diese enthaltende pharmazeutische mittel zur therapeutischen behandlung der epilepsie.

Country Status (7)

Country Link
EP (1) EP0309421B1 (de)
JP (1) JPH01102055A (de)
AT (1) ATE82567T1 (de)
DE (1) DE3876058T2 (de)
ES (1) ES2052776T3 (de)
GR (1) GR3006385T3 (de)
IT (1) IT1211792B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
MXPA05013975A (es) * 2003-06-23 2006-03-09 Neurochem Int Ltd Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
KR101608445B1 (ko) 2006-10-12 2016-04-01 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
CA2733390A1 (en) 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419097A (en) * 1973-03-27 1975-12-24 Procter & Gamble Ltd Preparation of sulphobetaines
US4246194A (en) * 1977-12-08 1981-01-20 Research Organics, Inc. Amino-hydroxy-alkyl sulfonic acid-zwitterions
DE3337026A1 (de) * 1983-10-12 1985-04-25 Henkel KGaA, 4000 Düsseldorf Aminoxidsulfonate
EP0213054B1 (de) * 1985-05-09 1990-08-01 Sherex Chemical Company, Inc. Alkaliverträgliche amphoterische Sulfobetain-Tenside
US4891159A (en) * 1986-08-27 1990-01-02 Miranol Inc. Low-foam alkali-stable amphoteric surface active agents

Also Published As

Publication number Publication date
GR3006385T3 (de) 1993-06-21
JPH01102055A (ja) 1989-04-19
IT1211792B (it) 1989-11-03
DE3876058T2 (de) 1993-03-25
ES2052776T3 (es) 1994-07-16
IT8748404A0 (it) 1987-09-21
EP0309421A2 (de) 1989-03-29
DE3876058D1 (de) 1992-12-24
JPH0565503B2 (de) 1993-09-17
EP0309421A3 (en) 1990-05-02
EP0309421B1 (de) 1992-11-19

Similar Documents

Publication Publication Date Title
AU4257889A (en) Sulphonamido-phenylalkanoic acid derivatives having thromboxane A2 antagonist activity
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
ATE123944T1 (de) Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
DE3876058D1 (de) 0-alkanoyl-derivate der 3-amino-2-hydroxypropanesulfonsaeure mit antikonvulsiver wirkung und diese enthaltende pharmazeutische mittel zur therapeutischen behandlung der epilepsie.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
ATE135573T1 (de) Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
DE69030665D1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate
DE3768516D1 (de) Chinonamide, deren herstellung und anwendung.
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DE68903019D1 (de) 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridin-derivate und isomere.
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
IT1223395B (it) Composti ad attivita' cardiovascolare
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
GB8608893D0 (en) D-nor-7-ergoline derivatives
ATE23856T1 (de) Derivate der d-2-(6-methoxy-2-naphthyl)propions|ure mit therapeutischer wirkung, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
ATE56706T1 (de) 4-methoxyisophthalsaeurederivat mit pharmakologischer wirksamkeit gegen thromboembolische erkrankung und verfahren zu dessen herstellung.
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee